Policy

Insurers and PBMs are implementing “co-pay accumulator” programs – an effort to prevent funds provided by manufacturer assistance programs from…

Adopting foreign price controls on innovative medicines would severely chill investment in new cures and therapies for diseases and jeopardize access…